⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

May 4, 2022Frontiers in PharmacologyOpen Access

A Four-Gene Prognostic Signature Based on the TEAD4 Differential Expression Predicts Overall Survival and Immune Microenvironment Estimation in Lung Adenocarcinoma

Xiaoxia Gong Ning Li Chen Sun Zhaoshui Li Hao Xie

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

is an immune regulation-related predictor of prognosis and a novel therapeutic target for LUAD.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Gong et al. (2022) studied this question.

synapsesocial.com/papers/6a025760dc09a3db38b3664e https://doi.org/10.3389/fphar.2022.874780

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1B21-04 A Prognostic Risk Model Based on the Tumor Microenvironment in Lung AdenocarcinomaOriginal Research · 2026
2Identification and Verification of Metabolism-related Immunotherapy Features and Prognosis in Lung Adenocarcinoma2024 · 6 citations
3Development and Validation of a Seven‐Gene Signature for Predicting the Prognosis of Lung AdenocarcinomaPrognostic Study · 2020 · 10 citations
4A Novel Gene Signature Based on Immune Cell Infiltration Landscape Predicts Prognosis in Lung Adenocarcinoma Patients2024 · 7 citations
5Identification of a three-gene prognostic signature associated with tumor immune characteristics in lung adenocarcinoma: A comprehensive analysis of multi-omics dataOriginal Research · 2026